Reducing Cardiovascular Disease in Patients with Type 1 Diabetes
May 19, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Mia Flowers, PharmD. Candidate of Florida Agricultural & Mechanical University School of Pharmacy
Patients with type 1 diabetes should not be excluded when considering statin therapy.
Numerous previous studies have evaluated the necessity of statins as dyslipidemia therapy in patients with type 2 diabetes. However, there has not been much research on the treatment that lowers lipids in patients with type 1 diabetes. The goal of this BMJ article was to conduct a risk assessment of cardiovascular disease by studying the adherence to lipid-lowering medications in the desired patient population. With dyslipidemia being preventable and controllable by lifestyle modifications that also reduce cardiovascular disease, it is essential to know how decreasing lipids could impact patients with type 1 diabetes....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.